SUN-155 Clinical Experience of SGLT2 Inhibitors in a Hispanic Population: Should We Consider Its Use as Add-On Treatment?

por Zayas, Francisco, Iriarte, R, Vergne, Norma, Hernandez, Luis, Gonzalez, Alex, Mangual, Michelle
Publicado 2019

Mucin-1 Gene Mutation and the Kidney: The Link between Autosomal Dominant Tubulointerstitial Kidney Disease and Focal and Segmental Glomerulosclerosis

por Trimarchi, H., Paulero, M., Rengel, T., González-Hoyos, I., Forrester, M., Lombi, F., Pomeranz, V., Iriarte, R., Iotti, A.
Publicado 2018

Podocyturia: A Clue for the Rational Use of Amiloride in Alport Renal Disease

por Trimarchi, H., Canzonieri, R., Muryan, A., Schiel, A., Araoz, A., Paulero, M., Andrews, J., Rengel, T., Forrester, M., Lombi, F., Pomeranz, V., Iriarte, R., Zotta, E.
Publicado 2016

In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?

por Trimarchi, H., Paulero, M., Canzonieri, R., Schiel, A., Iotti, A., Costales-Collaguazo, C., Stern, A., Forrester, M., Lombi, F., Pomeranz, V., Iriarte, R., Rengel, T., Gonzalez-Hoyos, I., Muryan, A., Zotta, E.
Publicado 2017

Increased urinary CD80 excretion and podocyturia in Fabry disease

por Trimarchi, H., Canzonieri, R., Schiel, A., Costales-Collaguazo, C., Politei, J., Stern, A., Paulero, M., Rengel, T., Andrews, J., Forrester, M., Lombi, M., Pomeranz, V., Iriarte, R., Muryan, A., Zotta, E., Sanchez-Niño, M. D., Ortiz, A.
Publicado 2016